CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis

Koichi Narikawa, Tatsuro Misu, Kazuo Fujihara, Ichiro Nakashima, Shigeru Sato, Yasuto Itoyama

Research output: Contribution to journalArticlepeer-review

67 Citations (Scopus)


The pathogenesis of relapsing neuromyelitis optica (RNMO) remains unknown. We, for the first time, studied the levels of four chemokines in the cerebrospinal fluid in RNMO with ELISA and compared the data with those in multiple sclerosis (MS) and control. CXCL10/IP-10 and CCL17/TARC were significantly elevated in both RNMO and MS. Conversely, CCL2/MCP-1 was significantly lower in MS, but not in RNMO, than in control. CCL11/Eotaxin was not different between groups. None of the four chemokines studied was significantly different between RNMO and MS.

Original languageEnglish
Pages (from-to)182-186
Number of pages5
JournalJournal of Neuroimmunology
Issue number1-2
Publication statusPublished - 2004 Apr


  • Chemokine
  • Multiple sclerosis
  • Relapsing neuromyelitis optica

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Neurology
  • Clinical Neurology


Dive into the research topics of 'CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis'. Together they form a unique fingerprint.

Cite this